Biogen
Boehringer Ingelheim International GmbH
F. Hoffmann-La Roche AG
GlaxoSmithKline Plc
Merck & Co. Inc. Novartis AG
Pfizer Inc. Sanofi S.A
Teva Pharmaceutical Industries Ltd. and UCB S.A
Published | Pages | Publisher | Report code |
---|---|---|---|
Nov 2023 | 143 | iMarc Group | ASDR-639961 |
Biogen
Boehringer Ingelheim International GmbH
F. Hoffmann-La Roche AG
GlaxoSmithKline Plc
Merck & Co. Inc. Novartis AG
Pfizer Inc. Sanofi S.A
Teva Pharmaceutical Industries Ltd. and UCB S.A